[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359102-105":59,"doc-detail-359102-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microbiota-in-pancreatic-ductal-adenocarcinoma-progression-and-therapy-the-hidden-players","Microbiota in pancreatic ductal adenocarcinoma progression and therapy - The hidden players","","Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal epithelial malignancy with rising incidence and substantial cancer-related mortality. Over the past decade, evidence indicates that microbiota influence both PDAC oncogenesis and resistance to chemotherapy. Preclinical and clinical findings demonstrate that microbiota shape therapeutic outcomes in PDAC patients. This review summarizes microbiota roles and mechanisms, emphasizing clinical implications and translational potential, and discusses microbiome-based therapies to improve treatment efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiota-in-pancreatic-ductal-adenocarcinoma-progression-and-therapy-the-hidden-players/359102/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiota-in-pancreatic-ductal-adenocarcinoma-progression-and-therapy-the-hidden-players/359102.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does microbiota affect PDAC progression and chemotherapy resistance?","Question",{"text":112,"@type":113},"Microbiota are linked to PDAC initiation, progression, and resistance to chemotherapy. Emerging evidence also connects dysbiosis and tumor microenvironment microbes with poorer outcomes and treatment refractoriness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What kinds of organisms make up the healthy microbiota mentioned in the review?",{"text":117,"@type":113},"The review describes a microbiota ecosystem comprising bacteria, fungi, viruses, archaea, and parasites, which supports host homeostasis and normal physiological functions.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are microbiome-targeted therapies considered potentially beneficial for PDAC?",{"text":121,"@type":113},"Because microbiota can modulate tumor behavior and influence therapeutic responses, targeting the microbiota is proposed as a strategy to enhance the effectiveness of existing PDAC treatments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359102,1790193883,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","| Review Article |\n| --- |\n| Microbiota in pancreatic ductal adenocarcinoma progression and therapy: The hidden players\u003Cbr>Xiulin Hu1, Fanyang Kong1, Jiayu Chen2, Zhaoshen Li2, Zhenzhai Cai3, Xiangyu Kong1\u003Cbr>1Department of Gastroenterology, Changhai Hospital, National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai 200433, China; 2Shanghai Institute of Pancreatic Diseases, Shanghai 200433, China;\u003Cbr>3Department of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China. |\n| Abstract\u003Cbr>Pancreatic ductal adenocarcinoma (PDAC), the deadliest epithelial malignancy, is increasingly prevalent and contributes significantly to cancer-related mortality. Research over the past decade has demonstrated that microbiota may play a pivotal role in both PDAC oncogenesis and its resistance to chemotherapy. Emerging preclinical and clinical data highlight the impact of microbiota on therapeutic outcomes in PDAC patients. This review systematically explores the role and underlying mechanisms of microbiota in PDAC, with a particular focus on their clinical implications and translational potential in disease progression and therapeutic responses. Finally, this review addresses the potential of microbiome-based therapies to enhance the efficacy of PDAC treatments. Keywords: Pancreatic cancer; Microbiota; Therapeutic resistance; Metabolites |\n\nIntroduction  \nA healthy microbiota, comprising bacteria, fungi, viruses, archaea, and parasites, is vital for maintaining homeostasis within the human host, which is essential for normal physiological functions. [1,2] The microbiota interacts with numerous body systems, including modulating immune responses, regulating food intake, participating in vitamin biosynthesis, defending against exogenous pathogens, and producing antimicrobial substances. [3–5] Disruption of this ecosystem can compromise host health, as it is associated with a wide range of diseases, including gastrointestinal disorders, neurological and respiratory conditions, metabolic diseases, liver disorders, and various cancers. [6–9]  \nPancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal 5-year survival rate of just 10% . [10–12] In recent years, increasing interest has focused on the microbiota characteristics of PDAC. Growing evidence highlights the microbiota’s pivotal role in tumor initiation, progression, and resistance to therapy. [13,14] The relationship between the microbiota and PDAC is multifaceted. Periodontitis, primarily driven by microbial infection, has been linked to several malignancies, including PDAC, lung cancer, and renal cancer. [15,16] Microbes associated with periodontal diseases, such as Fusobacterium nucleatum and Porphyromonas gingivalis (P. gingivalis), have been shown to play causal roles in PDAC  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003986 |\n\ninitiation. [17–19] Dysbiosis of the gut microbiota, characterized by an imbalance of microbial species, significantly affects PDAC, with evidence suggesting that fecal microbiota from tumor-bearing individuals can promote tumor growth. [20,21] Furthermore, the presence of microbiota within the tumor microenvironment is associated with PDAC progression and therapeutic resistance, with fungal colonization correlating with poorer patient prognosis. [22] For instance, Gammaproteobacteria in tissue may disrupt the metabolism of chemotherapeutic agents, contributing to drug resistance. [23] These findings have significant clinical implications, as targeting the microbiota may provide a novel strategy to enhance the effectiveness of existing PDAC treatments.  \nThis review offers an overview of the complex relationship between microbiota and PDAC, along with the microbial composition in PDAC. Mechanistic investigations have highlighted the role of microb","cbCaihaWz2QfsuBz","https://ap.wps.com/l/cbCaihaWz2QfsuBz","pdf",16472644,12,"English","# Abstract\n# Introduction\n# Microbiota Composition in PDAC\n## Bacterial dysbiosis","[{\"question\":\"How does microbiota affect PDAC progression and chemotherapy resistance?\",\"answer\":\"Microbiota are linked to PDAC initiation, progression, and resistance to chemotherapy. Emerging evidence also connects dysbiosis and tumor microenvironment microbes with poorer outcomes and treatment refractoriness.\"},{\"question\":\"What kinds of organisms make up the healthy microbiota mentioned in the review?\",\"answer\":\"The review describes a microbiota ecosystem comprising bacteria, fungi, viruses, archaea, and parasites, which supports host homeostasis and normal physiological functions.\"},{\"question\":\"Why are microbiome-targeted therapies considered potentially beneficial for PDAC?\",\"answer\":\"Because microbiota can modulate tumor behavior and influence therapeutic responses, targeting the microbiota is proposed as a strategy to enhance the effectiveness of existing PDAC treatments.\"}]","Microbiota in pancreatic ductal adenocarcinoma progression and therapy - The hidden players | PDF",1790136119,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/996300794efa6ae17f9a3e18ca5fc59e.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72d8969d58b1f69ea168e9d4173549df.webp",982,1323,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b06df2c8b8ed917ab9c21595498efa7.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27b1f2eb7c25f65da863bf80c4e35d2a.webp",980,1320]